Next Oncology

Clinical research site in Fairfax, Virginia · 3700 JOSEPH SIEWICK DR, SUITE 202, FAIRFAX, VA 22033-1744 · (703) 648-9700

Part of NEXT Oncology

As of July 2026, 25 paid clinical trials are recruiting at Next Oncology in Fairfax, Virginia. Active studies at this site cover conditions such as Solid Tumor and Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Next Oncology (25)

A Study of TAK-505 in Adults With Solid Tumors

for Malignant Solid Tumors

15 locations incl. Orange

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT07436728·Phase 1, Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

for Breast Cancer

14 locations incl. Orlando

Sponsor: Terremoto Biosciences Inc.

Sex: All·Age: 18+

Code: NCT07109726·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

for Gastric or Gastroesophageal Junction Adenocarcinoma

10 locations incl. Duarte

Sponsor: Phanes Therapeutics

Sex: All·Age: 18+

Code: NCT05482893·Phase 1, Phase 2·Recruiting·Listed Aug 2022

Apply to this trial

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

for PDAC

18 locations incl. Scottsdale

Sponsor: Tango Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06922591·Phase 1, Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

for Non-small Cell Lung Cancer

22 locations incl. Birmingham

Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All·Age: 18+

Code: NCT06343402·Phase 1·Recruiting·Listed Apr 2024

Apply to this trial

A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

for Advanced or Metastatic Solid Tumors

10 locations incl. Scottsdale

Sponsor: Incendia Therapeutics

Sex: All·Age: 18+

Code: NCT05753722·Phase 1·Recruiting·Listed Mar 2023

Apply to this trial

A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

for Ovarian Cancer

14 locations incl. Denver

Sponsor: OnCusp Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06234423·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

for Cancer

15 locations incl. San Francisco

Sponsor: MBrace Therapeutics

Sex: All·Age: 18+

Code: NCT06014658·Phase 1, Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

for Solid Tumors

17 locations incl. Duarte

Sponsor: ORIC Pharmaceuticals

Sex: All·Age: 18+

Code: NCT05315700·Phase 1, Phase 2·Recruiting·Listed Apr 2022

Apply to this trial

A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors

for Locally Advanced (Unresectable) or Metastatic Solid Tumors

8 locations incl. New York

Sponsor: NEOK Bio, Inc.

Sex: All·Age: 18+

Code: NCT07612189·Phase 1·Recruiting·Listed May 28, 2026

Apply to this trial

A Phase 1 Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors

for Locally Advanced (Unresectable) or Metastatic Solid Tumors

8 locations incl. New York

Sponsor: NEOK Bio, Inc.

Sex: All·Age: 18+

Code: NCT07612176·Phase 1·Recruiting·Listed May 28, 2026

Apply to this trial

A Study of HLD-0117 in Patients With Metastatic Breast Cancer

for Metastatic Breast Cancer

4 locations incl. New Haven

Sponsor: Halda Therapeutics OpCo, Inc.

Sex: Female·Age: 18+

Code: NCT07524855·Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer

for Breast Cancer

8 locations incl. Los Angeles

Sponsor: Boundless Bio, Inc.

Sex: All·Age: 18+

Code: NCT07408089·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

for Colorectal Cancer

8 locations incl. Duarte

Sponsor: Cartography Biosciences

Sex: All·Age: 18+

Code: NCT07321106·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

for Locally Advanced Solid Tumor

6 locations incl. New Haven

Sponsor: Ipsen

Sex: All·Age: 18+

Code: NCT07213817·Phase 1, Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors

for Colorectal Neoplasms

4 locations incl. Sarasota

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07107230·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

4 locations incl. Sarasota

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT05765851·Phase 1·Recruiting·Listed Mar 2023

Apply to this trial

Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid Tumors

for Selected Types of Solid Tumor

3 locations incl. New York

Sponsor: Everest Medicines (Beijing) Co., Ltd.

Sex: All·Age: 18+

Code: NCT07095868·Phase 1, Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

for Advanced Metastatic Castration Resistant Prostate Cancer

7 locations incl. Scottsdale

Sponsor: Shenzhen Ionova Life Sciences Co., Ltd.

Sex: Male·Age: 18+

Code: NCT06609005·Phase 1, Phase 2·Recruiting·Listed Sep 2024

Apply to this trial

Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

for Non Small Cell Lung Cancer

5 locations incl. Huntersville

Sponsor: Phanes Therapeutics

Sex: All·Age: 18+

Code: NCT05431270·Phase 1, Phase 2·Recruiting·Listed Jun 2022

Apply to this trial

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

for Solid Tumor

6 locations incl. Lake Success

Sponsor: STORM Therapeutics LTD

Sex: All·Age: 18+

Code: NCT06975293·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

for Cancer

6 locations incl. Los Angeles

Sponsor: Angiex, Inc.

Sex: All·Age: 18+

Code: NCT06440005·Phase 1·Recruiting·Listed Jun 2024

Apply to this trial

Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC

for Non-small Cell Lung Cancer(NSCLC)

1 location in Fairfax

Sponsor: LG Chem

Sex: All·Age: 18+

Code: NCT06332755·Phase 1·Recruiting·Listed Mar 2024

Apply to this trial

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK202 in Participants with Advanced Solid Tumors

for Advanced Cancer

2 locations incl. Margate

Sponsor: Shanghai Allink Biotherapeutics Co., Ltd.

Sex: All·Age: 18 - 75

Code: NCT06707610·Phase 1·Recruiting·Listed Nov 2024

Apply to this trial

A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors

for Solid Tumor

2 locations incl. Houston

Sponsor: Chugai Pharmaceutical

Sex: All·Age: 18+

Code: NCT05907980·Phase 1·Recruiting·Listed Jun 2023

Apply to this trial

More research sites in Fairfax

NEXT Virginia (72 trials)
Virginia Cancer Specialists (65 trials)
Inova Schar Cancer Institute (57 trials)
NEXT Oncology Virginia (29 trials)
Virginia Cancer Specialists, PC (17 trials)
Inova Fair Oaks Hospital (14 trials)
Re:Cognition Health (7 trials)
Inova Schar Cancer (6 trials)
Inova Fairfax Hospital (5 trials)
NEXT Oncology - Virginia (5 trials)

Explore more

Paid clinical trials in Fairfax, VA · Virginia clinical trials